A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States

Michelle E J Allerdice, Bobbi S. Pritt, Lynne M. Sloan, Christopher D. Paddock, Sandor E. Karpathy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Ehrlichia muris-like agent (EMLA) is an emerging, tick-transmitted human pathogen that occurs in the upper Midwestern United States. Here, we describe the development and validation of a p13-based quantitative real-time PCR TaqMan assay to detect EMLA in blood or tissues of ticks, humans, and rodents. The primer and probe specificities of the assay were ascertained using a large panel of various Ehrlichia species and other members of Rickettsiales. In addition to control DNA, both non-infected and EMLA-infected human blood, Mus musculus blood, and M. musculus tissue extracts were evaluated, as were non-infected and EMLA-infected Ixodes scapularis and uninfected Dermacentor variabilis DNA lysates. The specificity of the probe was determined via real-time PCR. An EMLA p13 control plasmid was constructed, and serial dilutions were used to determine the analytical sensitivity, which was found to be 1 copy per 4. μl of template DNA. The sensitivity and specificity of this assay provides a powerful tool for ecological studies involving arthropod vectors and their mammalian hosts.

Original languageEnglish (US)
Pages (from-to)146-149
Number of pages4
JournalTicks and Tick-borne Diseases
Volume7
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Ehrlichia muris
Midwestern United States
Ehrlichia
Real-Time Polymerase Chain Reaction
quantitative polymerase chain reaction
pathogens
assays
Mus musculus
Ticks
ticks
blood
DNA
Rickettsiales
Dermacentor variabilis
Arthropod Vectors
Ixodes scapularis
Dermacentor
Ixodes
Tissue Extracts
arthropods

Keywords

  • Ehrlichia muris
  • Ehrlichia muris-like (EML) agent
  • Ehrlichiosis
  • Tick-borne disease

ASJC Scopus subject areas

  • Infectious Diseases
  • Insect Science
  • Parasitology
  • Microbiology

Cite this

A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States. / Allerdice, Michelle E J; Pritt, Bobbi S.; Sloan, Lynne M.; Paddock, Christopher D.; Karpathy, Sandor E.

In: Ticks and Tick-borne Diseases, Vol. 7, No. 1, 01.02.2016, p. 146-149.

Research output: Contribution to journalArticle

Allerdice, Michelle E J ; Pritt, Bobbi S. ; Sloan, Lynne M. ; Paddock, Christopher D. ; Karpathy, Sandor E. / A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States. In: Ticks and Tick-borne Diseases. 2016 ; Vol. 7, No. 1. pp. 146-149.
@article{11ca17ce775148a691119e98e329a687,
title = "A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States",
abstract = "The Ehrlichia muris-like agent (EMLA) is an emerging, tick-transmitted human pathogen that occurs in the upper Midwestern United States. Here, we describe the development and validation of a p13-based quantitative real-time PCR TaqMan assay to detect EMLA in blood or tissues of ticks, humans, and rodents. The primer and probe specificities of the assay were ascertained using a large panel of various Ehrlichia species and other members of Rickettsiales. In addition to control DNA, both non-infected and EMLA-infected human blood, Mus musculus blood, and M. musculus tissue extracts were evaluated, as were non-infected and EMLA-infected Ixodes scapularis and uninfected Dermacentor variabilis DNA lysates. The specificity of the probe was determined via real-time PCR. An EMLA p13 control plasmid was constructed, and serial dilutions were used to determine the analytical sensitivity, which was found to be 1 copy per 4. μl of template DNA. The sensitivity and specificity of this assay provides a powerful tool for ecological studies involving arthropod vectors and their mammalian hosts.",
keywords = "Ehrlichia muris, Ehrlichia muris-like (EML) agent, Ehrlichiosis, Tick-borne disease",
author = "Allerdice, {Michelle E J} and Pritt, {Bobbi S.} and Sloan, {Lynne M.} and Paddock, {Christopher D.} and Karpathy, {Sandor E.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.ttbdis.2015.10.004",
language = "English (US)",
volume = "7",
pages = "146--149",
journal = "Ticks and Tick-borne Diseases",
issn = "1877-959X",
publisher = "Elsevier GmbH",
number = "1",

}

TY - JOUR

T1 - A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States

AU - Allerdice, Michelle E J

AU - Pritt, Bobbi S.

AU - Sloan, Lynne M.

AU - Paddock, Christopher D.

AU - Karpathy, Sandor E.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The Ehrlichia muris-like agent (EMLA) is an emerging, tick-transmitted human pathogen that occurs in the upper Midwestern United States. Here, we describe the development and validation of a p13-based quantitative real-time PCR TaqMan assay to detect EMLA in blood or tissues of ticks, humans, and rodents. The primer and probe specificities of the assay were ascertained using a large panel of various Ehrlichia species and other members of Rickettsiales. In addition to control DNA, both non-infected and EMLA-infected human blood, Mus musculus blood, and M. musculus tissue extracts were evaluated, as were non-infected and EMLA-infected Ixodes scapularis and uninfected Dermacentor variabilis DNA lysates. The specificity of the probe was determined via real-time PCR. An EMLA p13 control plasmid was constructed, and serial dilutions were used to determine the analytical sensitivity, which was found to be 1 copy per 4. μl of template DNA. The sensitivity and specificity of this assay provides a powerful tool for ecological studies involving arthropod vectors and their mammalian hosts.

AB - The Ehrlichia muris-like agent (EMLA) is an emerging, tick-transmitted human pathogen that occurs in the upper Midwestern United States. Here, we describe the development and validation of a p13-based quantitative real-time PCR TaqMan assay to detect EMLA in blood or tissues of ticks, humans, and rodents. The primer and probe specificities of the assay were ascertained using a large panel of various Ehrlichia species and other members of Rickettsiales. In addition to control DNA, both non-infected and EMLA-infected human blood, Mus musculus blood, and M. musculus tissue extracts were evaluated, as were non-infected and EMLA-infected Ixodes scapularis and uninfected Dermacentor variabilis DNA lysates. The specificity of the probe was determined via real-time PCR. An EMLA p13 control plasmid was constructed, and serial dilutions were used to determine the analytical sensitivity, which was found to be 1 copy per 4. μl of template DNA. The sensitivity and specificity of this assay provides a powerful tool for ecological studies involving arthropod vectors and their mammalian hosts.

KW - Ehrlichia muris

KW - Ehrlichia muris-like (EML) agent

KW - Ehrlichiosis

KW - Tick-borne disease

UR - http://www.scopus.com/inward/record.url?scp=84947447965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947447965&partnerID=8YFLogxK

U2 - 10.1016/j.ttbdis.2015.10.004

DO - 10.1016/j.ttbdis.2015.10.004

M3 - Article

C2 - 26507653

AN - SCOPUS:84947447965

VL - 7

SP - 146

EP - 149

JO - Ticks and Tick-borne Diseases

JF - Ticks and Tick-borne Diseases

SN - 1877-959X

IS - 1

ER -